GLP-1 receptor drugs for Chronic Kidney Disease

3 tracked GLP-1 receptor drugs in the Chronic Kidney Disease race. The class explanation lives on the GLP-1 receptor page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.

1 approved / phase 42 Phase 3

Head-to-head evidence: Safiglipron (HRS-7535) vs Semaglutide (Ozempic) · elecoglipron vs Semaglutide (Ozempic)

The roster

← all GLP-1 receptor drugs